A US and European perspective on how pricing reform could disrupt global launch plans (and how to respond)
FREE EDUCATIONAL WEBINAR
12 May 2026, 13:00 - 13:45 PM CET (*)
Most Favoured Nation (MFN) pricing has quickly become one of the most talked-about developments in US healthcare policy. But beyond the headlines, what does it actually mean for global pricing and, more importantly, for launch planning and execution?
In this 45-minute webinar, experts from Access Infinity will cut through the noise to explore what MFN could mean in practice. Drawing on insights from both US and European markets, they will highlight where the real risks lie for global teams and outline what actions you can take now to stay ahead.
You’ll leave with a clearer view of how different policy scenarios could play out and what they mean for your pricing across markets, launch sequencing, and overall strategy. We will also share practical approaches to help you stress-test your plans, anticipate downstream impact across markets, and build a more resilient, future-ready launch strategy.
About the experts:
Louisa Oliver Byrne and Megan O’Brien, expert trainers of Understanding Pharma Market Access in the US and Understanding Pharma Market Access & Payers in Europe, are highly experienced consultants specialising in global market access strategy:
Louisa Oliver Byrne leads Access Infinity’s US Managed Care Centre of Excellence. She has over seven years of experience in global pricing and market access consulting, with a strong focus on US-specific access strategy, value story development, and evidence generation.
Megan O'Brien is an Associate Director at Access Infinity with over 10 years of pharmaceutical consultancy experience, specialising in pricing and market access, real-world evidence generation, and business intelligence. She has led strategic partnerships for major pharmaceutical clients and brings deep expertise in payer needs and global market access strategy.
(*) If you cannot attend the webinar, please note that a recorded playback will be sent to all registrants after the webinar.